Arabic Arabic English English French French German German
dark

InterVenn Biosciences Announces That Arnold Levine Has Joined the Company’s Board of Advisors

InterVenn Biosciences today announced that Arnold Levine, Ph.D., has joined the Company’s Board of Advisors, effective March 19, 2021. Dr. Levine joins the InterVenn Board of Advisors as one of the pioneers of molecular cancer research. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

The Seven Stages of Alzheimer’s Disease Explained

Next Post

OneOncology Appoints Two New Board Members

Related Posts
Total
0
Share